Featured Research

from universities, journals, and other organizations

High Iron Levels Don't Increase Risk Of Death From Heart Disease, Study Finds

Date:
October 16, 2000
Source:
University At Buffalo
Summary:
The question of whether too much iron increases the risk of dying from heart disease has received another "no" answer through the results of a population-based, long-term, follow-up study conducted by researchers at the University at Buffalo.

BUFFALO, N.Y. -- The question of whether too much iron increases the risk of dying from heart disease has received another "no" answer through the results of a population-based, long-term, follow-up study conducted by researchers at the University at Buffalo.

The study, appearing in the October issue of Annals of Epidemiology, found no association between "high-normal" iron levels in the body and risk of death due to cardiovascular disease, coronary heart disease or heart attack, or between iron levels and risk of death from any cause.

Christopher Sempos, Ph.D., associate professor in the Department of Social and Preventive Medicine in the UB School of Medicine and Biomedical Sciences and lead author on the study, said of the findings: "Sound clinical guidance and public-health recommendations must be based on reasonably solid evidence that what is being recommended is both safe and effective.

"Currently available data do not support radical changes in dietary recommendations for iron intake or screening by physicians to detect high-normal levels of serum ferritin. Nor do they support the need for large-scale, randomized trials of dietary restriction or phlebotomy as a means of lowering iron stores."

There have been more than two dozen studies conducted in recent years on diseases of the heart and circulatory system and their association with levels of iron in the body, only a few of which showed positive findings, Sempos noted. Still, the subject remains controversial.

The current study was based on data collected from participants in the second National Health and Nutrition Examination Survey (NHANES II) between 1976 and 1980, and an analysis of death records through Dec. 31, 1992. The study sample consisted of 1,604 persons -- 128 black men and 100 black women; 658 white men and 718 white women -- between the ages of 45-74.

Iron status was based on concentrations of ferritin -- one of the chief forms in which iron is stored in the body -- in the serum of blood samples taken at the beginning of the study. Serum is the clear fluid that separates from blood when it clots.

Sempos and colleagues tested two hypotheses using this data: That any amount of excess iron increases heart-disease risk, and that only excess iron exceeding a high-normal level poses a risk.

Results showed:

• There was no statistically significant association between serum ferritin levels and death from any type of heart disease.

• There was no association between all-cause mortality and ferritin levels in white men or women of either race.

• Black men with low levels of excess iron in their serum were at three times the risk of death from any cause.

"Results from this study are consistent with others in showing that iron does not appear to play a direct role in the development of coronary heart disease," Sempos said. "More research needs to be done to study this issue in women and minorities."

Additional researchers on the study were Anne C. Looker, Ph.D., Richard F. Gillum, M.D., Cuong V. Vuong and Clifford L. Johnson, all of the National Center for Health Statistics, Centers for Disease Control and Prevention, and Daniel L. McGee, Ph.D., of Loyola University Stritch School of Medicine.


Story Source:

The above story is based on materials provided by University At Buffalo. Note: Materials may be edited for content and length.


Cite This Page:

University At Buffalo. "High Iron Levels Don't Increase Risk Of Death From Heart Disease, Study Finds." ScienceDaily. ScienceDaily, 16 October 2000. <www.sciencedaily.com/releases/2000/10/001013074108.htm>.
University At Buffalo. (2000, October 16). High Iron Levels Don't Increase Risk Of Death From Heart Disease, Study Finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/10/001013074108.htm
University At Buffalo. "High Iron Levels Don't Increase Risk Of Death From Heart Disease, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2000/10/001013074108.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins